Contact Us Locations About Products Pipeline Partnering Patients Investors & News Careers Products *Not an actual Rubraca Patient Rubraca-Approved for Indications in the U.S. If in the U.S. learn more about Rubraca by visiting the product website or by downloading prescribing information. DOWNLOAD FULL U.S. PRESCRIBING INFORMATION REQUEST U.S. MEDICAL INFORMATION Rubraca Authorized for Indication in Europe If a healthcare provider in Europe, for more information see news release. DOWNLOAD THE EUROPEAN APPROVAL NEWS RELEASE DOWNLOAD FULL EUROPEAN SUMMARY OF PRODUCT CHARACTERISTICS (INCLUDING NORTHERN IRELAND) DOWNLOAD FULL GREAT BRITAIN SUMMARY OF PRODUCT CHARACTERISTICS REQUEST EUROPEAN AND GREAT BRITAIN MEDICAL INFORMATION Medical Information - Adverse Events or Product Quality Complaints In the U.S., to report an adverse event related to use of a Clovis product, or if you have a product quality complaint, please contact the Medical Information department at 1-415-409-7220 (US toll), 1-844-CLVS ONC (1-844-258-7662; US toll-free), by email at medinfo@clovisoncology.com, or by using our website at clovismedicalinformation.com. In Europe, to report an adverse event related to use of a Clovis product, or if you have a product quality complaint, please click here for our country specific contact details About Pipeline Patients Investors & News Careers Contact Us Privacy Policy Cookie Policy Terms Sitemap COPYRIGHT © 2021 BY CLOVIS ONCOLOGY, ALL RIGHTS RESERVED. By using this website without changing your cookie settings, you agree to our use of cookies. For more information on how we use cookies, please see our Cookie Policy and Privacy Policy. By clicking Accept you consent to our use of cookies. Accept